Company Filing History:
Years Active: 2012
Title: Innovations in Therapeutics: The Contributions of Sergei V Zaitsev
Introduction
Sergei V Zaitsev is a notable inventor based in Elkins Park, Pennsylvania. He has made significant contributions to the field of therapeutics, particularly in the targeting of recombinant therapeutics to red blood cells. His innovative work has the potential to impact various medical conditions, including thrombosis and ischemic diseases.
Latest Patents
Zaitsev holds a patent for "Targeting recombinant therapeutics to circulating red blood cells." This patent describes fusion proteins that comprise a single chain antigen-binding domain of a monoclonal antibody, linked to an anti-thrombotic agent or anti-inflammatory agent. The polypeptide binds to a specific antigen expressed on the surface of red blood cells at a density greater than 5,000 copies per cell. The patent also outlines pharmaceutical compositions and methods for delivering these agents to treat or prevent conditions such as acute myocardial infarction and ischemic stroke.
Career Highlights
Zaitsev is affiliated with the University of Pennsylvania, where he continues to advance his research in therapeutic innovations. His work is characterized by a strong focus on improving the efficacy of treatments for serious medical conditions through targeted delivery systems.
Collaborations
Zaitsev has collaborated with esteemed colleagues, including Vladimir R Muzykantov and Bi-Sen Ding, who share his commitment to advancing medical science through innovative research.
Conclusion
Sergei V Zaitsev's contributions to the field of therapeutics exemplify the importance of innovation in medicine. His patented work on targeting red blood cells represents a significant advancement in the treatment of various diseases.